Introduction A quiet revolution is reshaping cancer research: patient‑derived organoids (PDOs) are elevating the study of tumors from flat, simplified systems to dynamic, three‑dimensional models that mirror the biology of individual cancers. Organoids are tiny, self‑organizing mini-tumors grown from a patient’s tissue or stem cells. In oncology, they recapitulate the architecture, genetic diversity, and microenvironment…